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Summary
This report describes a hierarchical screening technique
for identification of pathways that control the
morphogenesis of the renal collecting duct system. The
multi-step screen involves a first round using a
2-dimensional, cell-line-based scrape-healing assay,
then a second round using a 3-dimensional tubulogenesis
assay; both of these rounds use new cell lines described
in this report. The final stage is ex vivo organ culture.
We demonstrate the utility of the screen by using it to
identify the FAK–Src-pathway signalling as being
important for collecting duct development, specifically
for the cell proliferation on which this development
depends.
 2013. Published by The Company of Biologists Ltd. This is
an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial Share Alike
License (http://creativecommons.org/licenses/by-nc-sa/3.0).
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Introduction
This report has two main purposes: first, to describe an embryonic
cell-line-based system for screening pathways potentially involved
in renal collecting duct development and second, to present a novel
discovery about the importance of Src-family signalling to
collecting duct branching made using this system.
Driven by the need to understand congenital disease and to
invent methods for renal regeneration, there has been a strong and
steady growth in research into the basic mechanisms of
metanephric development. If the exponential increase in
discovery is to continue, especially in a period of fiscal
retrenchment, research methods will have to become significantly
more efficient than the transgenic approaches that have been
common so far. In hierarchical screening, common in the
pharmaceutical industry, simple cell-line-based assays are used as
a preliminary screen for interesting effects of pathway modulators.
Successively more sophisticated (but more labour-/time-intensive)
assays are then performed to test the short-listed candidates. The
selectivity of each stage greatly reduces the resources wasted on
candidate pathways that turn out not to be involved in an event of
interest; the approach also means that, by the time funding and
ethical permission have to be raised to support in vivo experiments,
a wealth of data from culture-based assays will already exist.
Assays to be used in the early steps of a hierarchical screening
programme demand well-characterised, immortal cell lines. The
traditional method for raising immortal cell lines – passaging a
primary culture to the Hayflick Limit (Hayflick and Moorhead,
1961) and cloning surviving colonies – has two disadvantages: it
is slow, and immortalisation depends on a stochastic, low-
probability event such as a mutation, the exact nature of which
will not be known and may interfere with subsequent
experiments. More deterministic alternatives exist, using the
conditional expression of an immortalising protein. Examples
include the ‘Immortomouse’, a transgenic animal whose cells can
be induced by gamma interferon to express a thermo-labile
mutant of the SV40 large T antigen (Jat et al., 1991; Salmon et
al., 2000; O’Hare et al., 2001), and ectopic expression of hTERT
on its own or with SV40 (Meyerson, 1998). In order to make cell
lines for hierarchical screening, we have raised immortal cell
lines from the ureteric buds of embryonic kidneys of
‘Immortomouse’ embryos. We have then characterised them in
terms of marker expression (expression of ‘anchor genes’ in the
language of Thiagarajan (Thiagarajan et al., 2011)) and
morphogenetic ability.
To demonstrate the application of a hierarchical screening
approach to renal development, we have designed a screening
strategy for candidate pathways that might control the
morphogenesis of the collecting duct system. The mature
urinary collecting duct system has the form of a branched
tubular tree, and it develops by multiple rounds of branching
from an initially unbranched ureteric bud (for reviews, see
Davies, 2001; Costantini, 2010). Its development is already
known to respond to a number of external signalling molecules,
including Gdnf, Fgfs, Bmps, angiotensin and components of the
basement membrane, and to a number of intracellular signalling
paths including MAP-kinase, PI-3-kinase Wnt/PCP and Rock (for
reviews, see Sakurai, 2003; Yosypiv, 2004; Michos, 2009).
Because maldevelopment of the collecting ducts is implicated in
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a number of renal diseases, including the relatively common
polycystic disease (for a review of the mechanisms of which, see
Al-Bhalal and Akhtar, 2008), there is strong interest in obtaining
a more complete view of all of the pathways that control its
development, and of their interactions. There are two
complementary approaches to this: the first is to gather high-
throughput expression data that can suggest candidate paths, an
approach exemplified by the studies of Brunskill et al. (Brunskill
et al., 2008) and the GUDMAP database (Harding et al., 2011);
the second is to test these candidates, ideally by an efficient and
relatively high-throughput technique.
The screening strategy described here begins with a simple,
two-dimensional screen for morphogenetic activity, based on the
‘healing’ of a scrape in an epithelial monolayer. This is then
followed, for short-listed candidates, by a three-dimensional
culture system using the same cell lines, and only then by testing
in ex vivo organ rudiments. Using this system, we show that
signalling by Src-family proteins and by focal adhesion kinase
(FAK) is critical for the normal development of the ureteric bud/
collecting duct system.
Results
Production and characterisation of ureteric bud cell lines
Kidney rudiments were isolated from ‘Immortomouse’ (H-2k-
tsA58) embryos, 11.5 days post coitum, and ureteric buds
(Fig. 1b) were isolated with the aid of dispase. These were
disaggregated enzymatically into cell suspensions that were
plated at low density and maintained in 5% CO2 at 33 C˚ in the
presence of IFNc. About 40 (s.d.54) clones per 5000 cells
formed over 5,10 days; 3 clones (6TA1,2,3) were expanded and
characterised further.
Each clone showed epithelial morphology and expressed the
ureteric bud marker protein, Pax2 (Dressler et al., 1990)
(Fig. 2a,b,c). Analysis by RT-PCR showed that they expressed
Ret and Hoxb7 (expressed throughout the early ureteric bud
(Pachnis et al., 1993; Watanabe and Costantini, 2004)), Sox9 and
Wnt11 (characteristic of ureteric bud tips (Kent et al., 1996; Lako
et al., 1998)) and Wnt9b and Col18 (characteristic of ureteric bud
stalk (Lin et al., 2001; Qian et al., 2003)) (Fig. 2d–f). All three
lines expressed all of these markers at different levels; as
populations, none had clearly ‘stalk’ or ‘tip’ identity in 2-
dimensional culture but showed a mix of both characteristics.
Given that tip and stalk can inter-convert freely depending on
their environment (Sweeney et al., 2008), expression of both may
reflect limitations of monolayer culture. All three cell lines also
expressed emx2 (empty spiracles homeobox 2), Axin2 (Axis
inhibition protein 2) and Zo1 (zona occludens 1) (Fig. 2d), all of
which are expressed in the normal ureteric bud (Miyamoto et al.,
1997; Marlier et al., 2009; Kiefer et al., 2010).
In culture, the cell lines formed confluent monolayers typical of
epithelial cells, making them suitable for use in scrape assays. In this
type of assay, a pipette tip is used to scrape a cell-free zone across
the monolayer; the subsequent ‘healing’ of the scrape involves many
aspects of epithelial morphogenesis, such as cells detecting the loss
of their neighbours, planar polarisation, formation of motile leading
edges, rearrangement of adhesive contacts, coordination of ‘purse-
string’ contraction and, when the edges meet, formation of new
adhesions, disassembly of motile structures and more changes in
polarity (Kirfel and Herzog, 2004; Lee et al., 2010). This type of
assay therefore has great potential as the first round in a hierarchical
screen (Yarrow et al., 2005). Our cell lines ‘healed’ scrapes steadily
over the course of 24–27 hours (micrographs of the process are
shown in the controls for the experiment in Fig. 4).
In vivo, the ureteric bud undergoes branching morphogenesis
to form the collecting duct system. Collecting duct-derived cells
such as mIMCD3 can make branching tubules in 3-dimensional
matrices when provided with mesenchyme-derived ramogenic
factors (Sakurai et al., 1997; Sakurai and Nigam, 1997). To test
whether our cell lines do this, we placed them in 3-dimensional
Matrigel gels and cultured them either in medium conditioned by
a metanephric mesenchyme line, Six5N6 (Tai et al., 2012)
(Fig. 3a–c) or in medium supplemented with the known
ramogens pleiotrophin, FGF1 and GDNF (Fig. 3d–f) (Sakurai
and Nigam, 1997). Cell lines 6TA1 and 6TA2 readily formed
branching systems of tubules. Cell line 6TA3 formed some short
tubes but it more typically made rounded cysts.
Use of the cell lines in a screen for pathways regulating
morphogenesis
Our hierarchical screening scheme (Fig. 1a) begins with scrape
assays, which are cost and labour-efficient, then promising
candidates are taken on to the more resource-intensive 3-
dimensional cell line tubule culture and only later move on to
ex vivo assays.
Using cell line 6TA2, which closes 95–100% of a scrape in
24–27 hours (Fig. 4a,b), we used a range of small-molecule
Fig. 1. Scheme and starting material. (a) The successive stages of the hierarchical screening strategy. (b) Isolated ureteric buds, examples of those used for the
creation of cell lines 6TA1, 2 and 3. Scale bar: 100 mm.
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inhibitors to test their effects on the rate of scrape closure. Some
acted on pathways known to be important in ureteric bud/
collecting duct morphogenesis, and were a positive control for
the assay, while others addressed pathways that have not been
explored in this tissue. The set of small molecules included
inhibitors of Akt kinase (124005), PI-3-kinase (LY294001),
Erk1/2 (U0126), JNK 1/2/3 (SP600125), p38 (SB203580),
CXCR4 receptor (AMD3100), G proteins (Pertussis toxin),
canonical Wnt signalling (IWR1), FAK (PF573228) and the
Src family (PP2 – with PP3 as an inactive relative – and
SU6656). Of these, IWR1, Pertussis Toxin and SB203580 had no
discernible effect at the concentrations used, AMD3100
accelerated scrape closure, and all of the others delayed or
inhibited scrape closure (Fig. 4c,d; Table 1).
The significant inhibition of closure produced by inhibition of
Akt and Jnk, by 124005 and SP600125 respectively, was
expected as these pathways had already been shown to be
important in collecting duct development (Tang et al., 2002;
Karner et al., 2009). The responses did, however, act as a positive
control for the assay. The responses to PP2 and PF573228
(Fig. 4e), which inhibit the Src family and FAK respectively,
were interesting because they suggested that Src-family
signalling might be important in collecting duct development,
something that has not been shown before.
Having established that Src-family signalling is required for
scrape closure in the cell-line-based primary screen, we went on
to test the effects of inhibiting this pathway in 3-dimensional
Matrigel culture of 6TA2 cells. The cultures were incubated for 7
days, and the number of distinct branches formed was used as a
quantitative measure of branching morphogenesis. The results
(Fig. 5) show that control cultures branched well, forming about
six branches, as did cultures in the inactive PP2 relative, PP3.
Cultures in the presence of the Src-family inhibitors PP2, SI-1
and SU6656, however, showed significantly reduced branching.
As was seen with the scrape assays, the FAK inhibitor PF573228
inhibited morphogenesis to the same extent as Src-family
inhibitors.
Verification of the importance of Src-family signalling to
collecting duct development, using organ culture
With FAK–Src-family signalling identified as being potentially
interesting in the first round screen, and shown to be required for
the branching morphogenesis of tubules in the second round
screen, there was sufficient evidence to justify final verification
in intact tissues. E11.5 mouse kidneys were cultured in control
medium or in the presence of the Src-family inhibitor PP2 or
SU6656, or in the FAK inhibitor PF573228, as used for the 6TA2
Fig. 2. Characterisation of cell lines 6TA1, 6TA2 and 6TA3. (a–c) All three
cell lines express nuclear Pax2 protein (red). Scale bar: 10 mm. (d) All three
cell lines, and embryonic kidney, express the general ureteric bud marker
mRNAs encoding Ret, Hox7b, emx2, axin2b, ZO-1 and irx3. (e,f) All cell lines
express the tip-specific mRNAs encoding Sox9 and Wnt11, and stalk-specific
markers Collagen 18 and Wnt9b; each cell type expresses all of these markers.
These are not at the same ratios, but in each case both stalk and tip markers are
present in two-dimensional culture. For reasons of space, these images have
been trimmed to show only the data bands; an example of a full experiment
with all primers and positive and negative RT-PCR controls can be viewed in
supplementary material Fig. S1.
Fig. 4. A primary screen based on scrape closure. In controls, a scrape in a
monolayer of 6TA2 cells, visible as the cell-free zone in a, is almost closed by
24 hours (b). In the presence of some inhibitors, scrape closure is greatly inhibited
(c,d). The effect of a range of inhibitors is summarised in Table 1; the effects of
inhibitors that focus on the Src–FAK system are shown quantitatively in (e). CK is
Control Kidney medium, DMSO is the vehicle control, while the other labels are the
names of drugs used at the concentrations shown in Table 1. Error bars show s.e.m;
*indicates significance at P,0.05, **indicates P,0.01, by a t-test comparison with
the control. Scale bars: 100 mm.
Fig. 3. Tubulogenesis by 6TA1,2,3 cells in 3-dimensional Matrigel, driven
by conditioned medium (a–c) or a mix of the ramogenic growth factors
pleiotrophin, FGF1 and GDNF (d–f). In both conditions, cell lines 6TA1 and
6TA2 form branching systems of tubules efficiently but line 6TA3 forms
structures that are more commonly cyst-like than tubular. Scale bars: 50 mm
(a–c); 100 mm (d–f).
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cell line. PP2 and SU6656 inhibited ureteric bud branching in a
dose-dependent manner (Fig. 6). Nephron progenitors formed in
the surrounding mesenchyme even in the presence of the
Src-family inhibitors. This indicates that the drugs were not
non-specifically toxic and also that the induction and early
development of nephron progenitors is much less dependent on
Src-family signalling than is ureteric bud development.
Treatment with the FAK inhibitor PF573228 had similar effects
up to 100 nM (Fig. 6i–l), although at 1 mM it inhibited nephron
formation as well and loss of tissue integrity suggested that, at
this concentration, it was simply toxic.
Cell proliferation in the tips of the ureteric bud is an important
driver of ureteric bud growth and branching (Michael and Davies,
2004). This, along with the facts that proliferation of a wide
variety of epithelial cells depends on signalling by the FAK–Src
pathway (Chaturvedi et al., 2007; Owen et al., 2011) and that
oncogenic mutations within this pathway can result in
uncontrolled proliferation (Fu et al., 2011; Serrels et al., 2012),
leads naturally to the hypothesis that the ureteric bud requires
Src–FAK signalling to maintain its normal rate of proliferation.
We tested this idea by examining the effect of FAK inhibition on
the frequency and distribution of phosphohistone H3-positive
Table 1. Effect of small-molecule pathway inhibitors on scrape closure by 6TA2 cells.
Drug Concentration Target Effect
124005 20 mM Akt kinase Inhibited closure
LY294002 20 mM PI-3-kinase Inhibited closure
U0126 20 mM MKK activation of Erk 1/2 Inhibited closure
PD98059 10 mM Mek1 Inhibited closure
SP600125 0.5 mM JNK 1/2/3 kinase and others Inhibited closure
SB203580 10 mM P38 MAP kinase, Src family No effect detected
AMD3100 20 mM CXCR4 receptor Accelerated closure
Pertussis toxin 1 mg/ml G-protein No effect detected
IWR1 10 mM Canonical Wnt No effect detected
PP2 20 mM Src family, RIP2 Inhibited closure
PP3 20 mM Inactive analogue No effect observed
Src Inhibitor 1 20 mM Src Inhibited closure
SU6656 5 mM Src family, CAMK Inhibited closure
PF573228 10 mM FAK Inhibited closure
Fig. 5. Effect of inhibiting Src or FAK signalling on branching
morphogenesis in 3-dimensional Matrigel culture. There is vigorous
branching in cells treated with the control (inactive) drug PP3 (a), but there is
less branching on average in PP2, SI-1 and PF573228 (b–d), although
occasional cysts do still branch, as can be seen in b. Scale bars: 100 mm. The
graph (e) shows the data quantitatively: DMSO is a solvent control and PP3 is
the inactive control for PP2. ***P,0.05.
Fig. 6. Inhibition of Src or FAK also inhibits collecting duct
morphogenesis (green: Calbindin-D-28K (Davies, 1994)) in cultured
kidneys, in a dose-dependent manner (a–l). Nephron progenitors, visible by
their having laminin-rich basement membranes (red) but no green stain,
continue to form; examples are marked with arrows in d and can be seen in all
images except l, in which the tissue is breaking down and the high
concentration of the drug appears to be toxic. Scale bars: 100 mm.
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(i.e. mitotic cells) cells in cultured embryonic kidneys. Controls
(Fig. 7a) showed abundant mitoses in the ureteric bud/collecting
duct system as well as in the surrounding mesenchyme, whereas
FAK-inhibited kidneys (Fig. 7b) showed far fewer in the
collecting ducts, and a modest reduction in the mesenchyme.
To separate the effects of inhibition on the bud from indirect
effects via the mesenchyme, and also to make the assay
quantitative, we compared the increase in cell number during 2
days of culture. The results (Fig. 7c) showed that inhibition of
either FAK or Src reduced proliferation significantly.
Expression of Src-family proteins in the cell lines and the kidney
Given that our results suggest that signalling by Src and FAK
proteins is important in renal morphogenesis, we established
which members of the Src family are expressed in this tissue. The
Src family of proteins is divided into two sub-families, SrcA (Src,
Fgr, Fyn and Yes) and SrcB (Blk, Hck, Lck, Lyn). To gain insight
into which are most likely to be involved in collecting duct
morphogenesis, we assessed the expression of the family
members in 6TA1 and 6TA2 cells and in embryonic kidneys.
6TA1 and 6TA2 cells express Src, Fyn, Yes, Lyn and Hck, but no
detectable Blk or Lck; the absence of this latter pair is not
surprising as they are restricted mainly to the immune system and
brain (Thomas and Brugge, 1997). Embryonic kidneys from
E11.5, E13.5 and adult show a similar pattern, except that Blk is
expressed transiently during development, being absent at E11.5,
present at E13.5 and absent again in the adult (Fig. 8). FAK is
expressed by the cells and by the kidney at all stages examined.
Discussion
In this report, we have described the development of
conditionally immortal cell lines from embryonic mouse
kidney, and have described the design of a hierarchical
screening strategy that uses the cell lines for identification of
signalling pathways important in ureteric bud development. We
have illustrated the utility of this system by using it to show that
signalling by Src-family proteins and by FAK is required for
collecting duct branching, something that was not known before.
That both the Src family and FAK are important is not
surprising. In typical cells, the non-receptor tyrosine kinase FAK
is activated by clustering of integrins as they bind to the
extracellular matrix (Mitra and Schlaepfer, 2006). Once
activated, FAK can go on to activate other pathways; amongst
the pathways that can be activated are those mediated by the Src
family, which lead on to paths such as MAP kinase and Jnk (Kim
et al., 2009; Cox et al., 2006). It is already known that
interactions between specific integrins (e.g. a6b1 and a8b1
(Falk et al., 1996; Linton et al., 2007)) and specific components
of the extracellular matrix (e.g. laminin and nephronectin (Yang
et al., 2011; Zhao and Guan, 2011)) are required for ureteric bud
development. Our data presented here suggest that FAK–Src-
family signalling may be one essential consequence of this
Fig. 7. Inhibition of Src or FAK reduces cell proliferation in the developing collecting duct. E11.5 mouse kidneys were cultured in control medium or in the
presence of Src- or FAK-inhibiting drugs and stained for Calbindin-D-28K (green, to reveal the developing collecting ducts) and phosphohistone H3 (PH 3: red, to
reveal proliferating cells). Examples of phosphohistone 3-positive cells in the collecting duct are marked with blue arrowheads in a (control) and b (PF573228); there
are clearly fewer in the presence of the inhibitor. A quantitative analysis for this and other inhibitors on cell proliferation in 6TA2 cells is also shown (c); **P,0.01.
Scale bar: 100 mm.
Fig. 8. Expression of Src-family proteins and FAK, in embryonic kidneys
and 6TA1/2 and mIMCD-3 cell lines, by RT-PCR. See supplementary
material Fig. S1 for an example of gels with control as well as data lanes.
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interaction. Indeed, the pathway might provide a critical link
between cell–matrix interactions and the intracellular pathways
already known to be essential for ureteric bud branching (e.g.
MAPkinase and PI-3-kinase). It is also interesting to note that
FAK–Src signalling is required for invasion of neoplastic cells
(Zhao and Guan, 2011), highlighting the parallel between
invasive behaviour of normal epithelia during developmental
events such as branching, and metastatic invasion by tumours.
For any experiment based on pharmacological inhibitors, the
question of specificity must be addressed. Fortunately, the
Table 2. Polymerase chain reaction (PCR) primers used in this study.
PCR primers of differentiation markers
Accession number Name Sequence Size of PCR product
NM_001080780.1 Ret GCGTCAGGGAGATGGTAAAG 210
CATCAGGGAAACAGTTGCAG
NM_010460 Hoxb7 TTCCCCGAACAAACTTCTTG 216
CGGAGAGGTTCTGCTCAAAG
NM_011448 Sox9 GTGGCAAGTATTGGTCAA 318
GAACAGACTCACATCTCT
NM_011719.4 Wnt9b AGGAGACGGCCTTCCTGTAT 398
GACAGCCGTGTCATAGCGTA
NM_009929 Col18 TATCCGTGGAGCAGATTTCC 181
CCTGACCTGTAGCCCCAGTA
NM_010132.2 Emx2 ACCTTCTACCCCTGGCTCAT 354
TCTCCACCGGTTAATGTGGT
NM_008393.3 Irx3 GCAAAACTAGCGACTCGGAC 586
GGCTGGAAAGCTGTCTTGAG
NM_015732.4 Axin2 GAGGTGGTACCTTGCCAAAA 539
TGCCAGTTTCTTTGGCTCTT
NM_009386.2 Zo1 CAGAAAACCATCACTCCGGT 624
TTGCCAGGTTTTAGGGTCAC
NM_011587.2 Tie1 CTCACTGCCCTCCTGACTGG 226
CGATGTACTTGGATATAGGC
NM_010612.2 Flk1 AGCTCTCCGTGGATCTGAAA 197
CCAAGAACTCCATGCCCTTA
NM_010228.3 VEGFR1 CGGAAGCTCTGATGATGTGA 198
TATCTTCATGGAGGCCTTGG
NM_011380 Six-2 AGCACCTCCACAAGAATGAAAG 401
GTTCTTGAACCAGTTGCTGACTT
NM_011037 Pax2 AGTGTCTCATCCATCAACAGGAT 626
GGTAGAGTGGTGCTCGTCATATC
NM_144783 WT1 CCACTCCTTCATCAAACAGGA 532
AGCTCCTAGGTTCATCTGATTCC
NM_001081088.1 Megalin CAGGGACTCCTCTGACGAAG 376
CCTCTCCTTCTGGACAGTCG
NM_130456.3 nphs2 GCATCAAGCCCTCTGGATTAG 232
AGACGGAGATCAACCTTGTGATA
NM_009788 CaBp-D28k AGTGGTTGTGGTCACCAACTCT 305
CCAGGTTACTACCAGTGCAGGA
XM_001479851 GAPDH TGATGACATCAAGAAGGTGGTGAAG 217
TCCTTGGAGGCCATGTAGGCCAT
EF579662.1 SV40Ts GAGTTTCATCCTGATAAAGGAGG 720
GTGGTGTAAATAGCAAAGCAAGC
PCR primers of Src family members
Accession number Name Sequence Size of PCR product
NM_009271 Src GAACCCGAGAGGGACCTTC 154
GCGGGAGGTGATGTAGAAACC
NM_008054 Fyn ACCTCCATCCCGAACTACAAC 135
CGCCACAAACAGTGTCACTC
NM_007982 FAK GAGTACGTCCCTATGGTGAAGG 108
CTCGATCTCTCGATGAGTGCT
NM_010693 Lck TGGAGAACATTGACGTGTGTG 120
ATCCCTCATAGGTGACCAGTG
NM_007549 Blk GAGGCAGGTCAGTGAGAAGG 127
GTCCTGGTTAGGAGATGGTGG
NM_009535 Yes AGTCCAGCCATAAAATACACACC 117
TGATGCTCCCTTTGTGGAAGA
NM_010208 fgR CGGCTGAAGAACGCTATTACC 138
GGGCGACGAATATGGTCACTC
NM_010747 Lyn GTGACATTGTGGTGGCCTTAT 105
ACCATTCCCCATGCTCTTCTA
NM_010407 Hck TCCTCCGAGATGGAAGCAAG 168
ACAGTGCGACCACAATGGTAT
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activities of the inhibitors used here have been studied carefully
against a large range of enzymes (Bain et al., 2007). Of the drugs
used here, PP2 has somewhat low specificity, inhibiting other
kinases such as Ck1delta (IC505170 nM), Csk (IC505640 nM)
and p38-MAP kinase (IC50<650 nM) as well as Src-family
kinases (IC50553 nM for Src, 40 nM for Lck) (Bain et al., 2007).
Src Inhibitor 1 (SI-1) inhibits Src and Lck (IC50544 nM and
88 nM respectively according to manufacturer’s data sheet,
IC505180 nM for Src according to Bain et al. (Bain et al.,
2007)); it also inhibits Csk (Bain et al., 2007). SU6656 shows
close specificity for Src and its closely related kinases, Fyn, Yes
and Lyn, (IC505280, 170, 20 and 130 nM respectively), but not
Lck (IC50.6000 nM) or other kinases (Blake et al., 2000). PP2
and SI-1 are known also to inhibit the kinase activity Receptor
Interacting Protein 2 (RIP2), which shares a very similar active
site (Bain et al., 2007). The other drugs may also show this
activity, although it has not been reported. This would be a
concern in cells that express Rip2, e.g. keratinocytes (Adams et
al., 2010) and T cells (Ruefli-Brasse et al., 2004), but published
microarray analysis of laser captured ureteric bud shows the
protein to be absent in this tissue, and indeed absent in all other
tissues of the early kidney (later, it becomes detectable only in
mature podocytes and glomerular epithelia; see the GUDMAP
website (http://www.gudmap.org)). This potential off-target
reaction is therefore not a concern here. Also, the FAK
inhibitor, which has the same effect on ureteric bud branching
as the Src-family inhibitors, has no known activity against Rip2.
Taken together, the effects of all of the drugs examined in this
report suggest strongly that the FAK–Src pathway is necessary
for ureteric bud development.
Beyond describing the importance of a specific pathway, this
report sets out to illustrate how a 3Rs-compliant, hierarchical
screening strategy can be used as an approach to identifying
pathways involved in renal development. The principle can be
used for a wide variety of investigations of renal development.
We have made the cell lines themselves freely available to the
community (‘free’ except for the cost of shipping) via the
GUDMAP website (http://www.gudmap.org; go to the mouse
lines and cell lines section).
Materials and Methods
Production of cell lines from ‘Immortomouse’ embryos
Kidney rudiments were obtained from embryos of H-2k-tsA58 (‘Immortomouse’)
mice at 11.5 days of gestation (the morning of vaginal plug discovery being
considered 0.5 days). The kidney rudiments were isolated by manual dissection in
Dulbecco’s Minimum Essential Medium (DMEM: D5546, Sigma Chemical
Corporation, Poole, UK). Rudiments were incubated for 5–10 minutes in 2 U/ml
dispase in PBS at room temperature (14–16 C˚) and fine needles were used to pull
the ureteric bud out of the mesenchyme, in an action similar to removing a hand
from a glove. Tissues were rinsed in DMEM, crudely chopped up using needles
and incubated for 2 minutes in Trypsin–EDTA in DMEM at 37 C˚. They were then
transferred to ‘IM’ (Immortalisation Medium): 1% ITS supplement (I2521,
Sigma), 100 U/ml IFNc (cyt-358, ProSpecBio), 16 glutamine–penicillin–
streptomycin from a joint stock solution (10378016, Invitrogen), 16 antioxidants
(A1345, Sigma) and 10% heat-inactivated foetal calf serum (Invitrogen) in 1:1
DMEM:F12 (D8437, Sigma). The tissues were reduced to a cell suspension by
trituration in a yellow tip, and plated on Matrigel-coated dishes in IM
supplemented with 10 mM Y27632 (Y0503, Sigma), an inhibitor of Rock, and
incubated at 33 C˚, 5% CO2 for 48 hours. After this, the medium was replaced with
plain IM and samples were incubated for a further 72–240 hours. In the
clonogenicity study, 10% FCS serum in DMEM medium was initially used to
optimise cell culture condition.
After this incubation, clones were isolated using cloning rings, and used to seed
new cultures. These were maintained at 33 C˚ in PM, which has the same
constitution as IM except that it contains only 20 U/ml IFNc. They were passaged
every 72 hours, using Trypsin–EDTA, being diluted 1:3 (and samples were frozen
in 90% FCS, 10% DMSO).
Reverse transcription polymerase chain reaction (RT-PCR)
Cells were collected from sub-confluent cultures and their total RNA was isolated
using QIAshredder and an RNeasy Mini Kit (Qiagen) according to the
manufacturer’s instructions. cDNA was synthesised using ImProm-IITM Reverse
Transcriptase (Promega). PCR was then performed using gene-specific DNA
primer pairs that were designed using the Primer3 programme and synthesised by
Eurofins MWG. The primers are listed in Table 2. The PCR programme was:
initial denaturation at 94 C˚ for 2.5 minutes, followed by 35 cycles of 94 C˚ for
30 seconds, 58 C˚ for 45 seconds 72 C˚ for 45 seconds, then final extension at 72 C˚
for 10 minutes. Controls include ‘no mRNA’, and ‘no RT’. Electrophoresis was
performed on a 0.8% agarose gel.
Scrape assays
Ureteric bud cell lines were passaged by brief digestion in pre-warmed 16
Trypsin–EDTA for 2 minutes, washed, and a suspension of separated cells
(verified by microscopic examination) was plated and cultured for 24,36 hours to
form a confluent monolayer. Scratch wound lines were made with a fine sterile
needle. The scraped monolayer was gently washed and incubated for 2 hours
(37 C˚, 5% CO2), before drugs were applied. Images were captured immediately
after drug was added (deemed 0 hours) and at times thereafter as indicated in the
results section.
Three-dimensional branch assays
Matrigel (BD Bioscience), stored at 220 C˚, was thawed on ice and 5 ml aliquots
were used to coat 13 mm glass coverslips, the Matrigel being spread on the
coverslip in a 24-well plate and the plate then being transferred to a 37 C˚ incubator
for ,5 minutes. A suspension of 56104 6TA1 or 6TA2 cells was mixed with
500 ml Matrigel solution (final concentration 9% in 5% FCS MEM medium) and
plated on to the coated coverslips, 50 ml (5000 cells) per coverslip. 50 ml
conditioned medium from a culture of the metanephric mesenchymal cell line
Six5N6 was added per well to induce branching morphogenesis. Complex trees
(6,8 tips) appeared between 5 and 10 days.
Ex vivo kidney culture
Kidney rudiments were isolated from E11.5 embryos of wild-type CD1 mice by
micro-dissection. They were cultured for 4 days on MilliporeTM polycarbonate
filters supported at the air-liquid interface in MEM medium (Invitrogen) with 10%
serum (FCS), with or without drugs (as specified in the Results section). Fixation
was in cold methanol for 10 minutes or (for anti-phosphohistone staining) in 4%
formaldehyde in PBS for 1 hour. After washing in PBS (with 0.1% Triton X-100
for formaldehyde-fixed specimens), specimens were incubated overnight at 4 C˚ in
1/100 anti-laminin (Sigma L9595) and 1/100 anti-calbindin (Abcam ab82812) and
1/200 anti-phosho-histone H3 (Cell Signalling Technologies 9701), in PBS.
Controls were maintained in PBS alone. After another PBS wash, samples were
incubated in a 1/100 dilution of the relevant secondary antibody (FITC anti-mouse,
Sigma F2012; FITC anti-rat, Sigma F6258; TRITC anti-rabbit, Sigma T6778) in
PBS for 4 hours at 4 C˚, washed in PBS and viewed on a Zeiss AxioScope
epifluorescence microscope.
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